What is the Artemis Medicare Services PE ratio today?
Artemis Medicare Services' PE ratio is 41.5 at the 29 October 2026 close (₹297.95 a share): a market capitalisation of ₹4,717 crore divided by consolidated net profit of ₹114 crore over the last four quarters (Q2 FY26 to Q1 FY27). On FY26 net profit (₹104 crore) it is 45.5.
What is the Artemis Medicare Services PB ratio (price to book value)?
Artemis Medicare Services' price-to-book (PB) ratio is 5.05 at the 29 October 2026 close: a market capitalisation of ₹4,717 crore divided by shareholders' equity (book value) of ₹935 crore on 31 March 2026. That is a book value of ₹59.04 per share against a share price of ₹297.95.
What is the Artemis Medicare Services debt to equity ratio?
Artemis Medicare Services' debt-to-equity ratio was 0.24 on 31 March 2026: borrowings of ₹227 crore against total equity of ₹941 crore. A year earlier, on 31 March 2025, it was 0.29.
What is the Artemis Medicare Services market cap?
Artemis Medicare Services' market capitalisation was ₹4,717 crore at the 29 October 2026 close: 15.83 crore shares at ₹297.95 each.
Is Artemis Medicare Services debt free?
No. Artemis Medicare Services had borrowings of ₹227 crore on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.24. Its cash and current investments were ₹206 crore, so its net debt was ₹20.7 crore.
What is the Artemis Medicare Services book value per share?
Artemis Medicare Services' book value per share was ₹59.04 on 31 March 2026: shareholders' equity of ₹935 crore divided by the 15.83 crore shares in issue. The share price at the 29 October 2026 close was ₹297.95.
What is the Artemis Medicare Services net worth?
Artemis Medicare Services' net worth — shareholders' equity in its consolidated balance sheet — was ₹935 crore on 31 March 2026, up 11.6% from ₹838 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹4,717 crore at the 29 October 2026 close.
What is the Artemis Medicare Services ROE and ROCE?
In FY26, Artemis Medicare Services' return on equity (ROE) was 11.7% and its return on capital employed (ROCE) was 11.9%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 12.9% and ROCE 11.1%.
What is the Artemis Medicare Services free cash flow?
In FY26, Artemis Medicare Services generated ₹132 crore of cash from operations and spent ₹105 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹27 crore. In FY25 it was ₹52.5 crore.
What is the Artemis Medicare Services EPS?
Artemis Medicare Services' basic earnings per share (EPS) were ₹6.56 in FY26, against ₹5.37 in FY25.
What is the Artemis Medicare Services dividend in 2026 and its record date?
In 2026, Artemis Medicare Services has declared one dividend: ₹0.45 with record date 10 July 2026.
When are the Artemis Medicare Services next results?
Artemis Medicare Services will announce its Q2 FY27 results (July–September 2026) on Friday, 30 October 2026, the date of the board meeting it has notified to the exchanges.
What are the Artemis Medicare Services latest quarterly results?
Artemis Medicare Services' latest results are for Q1 FY27 (April–June 2026), filed on 3 August 2026: consolidated net profit ₹31.3 crore, up 47.1% from ₹21.3 crore in Q1 FY26; revenue from operations ₹287 crore, up 12.7% year on year.
What is the Artemis Medicare Services revenue and profit in FY26?
In FY26 (April 2025–March 2026), Artemis Medicare Services' consolidated net profit was ₹104 crore, up 25.4% from ₹82.6 crore in FY25, on revenue from operations of ₹1,081 crore (up 15.4%). Over three years, from FY23, net profit was up 188.7%.
How does the Artemis Medicare Services PE ratio compare with its peers?
At the 29 October 2026 closing prices, on FY26 net profit, Artemis Medicare Services' PE ratio is 45.5, the second highest of the four: Indraprastha Medical Corporation 15.9, Shalby 35.1 and Gujarat Kidney And Super Speciality 87.4, a peer average of 46.1. Each is the company's market capitalisation at that price divided by its FY26 net profit.
How does Artemis Medicare Services compare with its peers?
On FY26 consolidated figures, against Indraprastha Medical Corporation, Shalby and Gujarat Kidney And Super Speciality: Artemis Medicare Services' operating margin of 13.0% is the third highest of the four (Indraprastha Medical Corporation 15.1%, Shalby 6.4%, Gujarat Kidney And Super Speciality 27.1%; peer average 16.2%); its return on equity of 11.7% is the second highest of the four (Indraprastha Medical Corporation 27.5%, Shalby 3.7%, Gujarat Kidney And Super Speciality 6.1%; peer average 12.5%).
Artemis Medicare Services vs Indraprastha Medical Corporation: how do they compare?
In FY26, Artemis Medicare Services earned net profit of ₹104 crore on revenue of ₹1,081 crore, against ₹184 crore on ₹1,483 crore for Indraprastha Medical Corporation. Artemis Medicare Services' operating margin was 13.0% (Indraprastha Medical Corporation 15.1%) and its return on equity 11.7% (Indraprastha Medical Corporation 27.5%). At the 29 October 2026 close, Artemis Medicare Services' market capitalisation was ₹4,717 crore against ₹2,918 crore for Indraprastha Medical Corporation, and its PE ratio on FY26 profit 45.5 against 15.9.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.
